Breakthrough Approval: UK Regulator Greenlights Moderna's RSV Vaccine for Seniors
2025-02-28Reuters
In a significant development, the UK's health regulator has approved Moderna's RSV vaccine for individuals aged 60 and above, offering protection against lower respiratory tract disease caused by the respiratory syncytial virus. This vaccine approval ...Read more
